Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Alli

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
DNA Repair|December 4, 2018
Correcting errors in the BRCA1 warning systemYanping Liang, William J Dearnaley, Nick A Alden, et al.
FASEB Bioadvances|March 4, 2020
Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivoJessica Swanner, Cale D Fahrenholtz, Iliana Tenvooren, et al.
Research Square|February 26, 2024
Repurposing mebendazole against triple-negative breast cancer leptomeningeal diseaseAdrian Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Breast Cancer Research and Treatment|October 30, 2013
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer riskShaveta Vinayak, Erich J Schwartz, Kristin Jensen, et al.
Journal of Neuro-Oncology|April 2, 2024
Repurposing mebendazole against triple-negative breast cancer CNS metastasisAdrian J Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
DNA Repair|December 4, 2018
Correcting errors in the BRCA1 warning systemYanping Liang, William J Dearnaley, Nick A Alden, et al.
FASEB Bioadvances|March 4, 2020
Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivoJessica Swanner, Cale D Fahrenholtz, Iliana Tenvooren, et al.
Research Square|February 26, 2024
Repurposing mebendazole against triple-negative breast cancer leptomeningeal diseaseAdrian Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Breast Cancer Research and Treatment|October 30, 2013
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer riskShaveta Vinayak, Erich J Schwartz, Kristin Jensen, et al.
Journal of Neuro-Oncology|April 2, 2024
Repurposing mebendazole against triple-negative breast cancer CNS metastasisAdrian J Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Pageof 2